Home/Filings/4/0001181431-05-051362
4//SEC Filing

Allaway Graham 4

Accession 0001181431-05-051362

CIK 0001040017other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 5:01 PM ET

Size

9.8 KB

Accession

0001181431-05-051362

Insider Transaction Report

Form 4
Period: 2005-09-09
Allaway Graham
Chief Operating Officer
Transactions
  • Exercise of In-Money

    Common stock

    2005-09-09$0.05/sh+25,377$1,251201,059 total
  • Exercise of In-Money

    Stock option (right to buy)

    2005-09-0925,3770 total
    Exercise: $0.05From: 2005-05-03Exp: 2010-11-14Common stock (25,377 underlying)
Holdings
  • Stock option (right to buy)

    Exercise: $0.23From: 2005-05-03Exp: 2014-06-01Common stock (660,584 underlying)
    660,584
  • Stock option (right to buy)

    Exercise: $0.17From: 2005-05-03Exp: 2012-01-24Common stock (202,584 underlying)
    202,584
Footnotes (2)
  • [F1]180,952 stock options are fully vested. 21,632 stock options will fully vest on January 25, 2006.
  • [F2]448,982 stock options are fully vested. 70,534 stock options will vest on each of April 30, 2006, April 30, 2007 and April 30, 2008.

Documents

1 file

Issuer

PANACOS PHARMACEUTICALS, INC.

CIK 0001040017

Entity typeother

Related Parties

1
  • filerCIK 0001329634

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:01 PM ET
Size
9.8 KB